Therapy Areas: Diabetes
Millendo Therapeutics Releases Topline Results for Pivotal Phase 2b Study of Livoletide in Patients with Prader-Willi Syndrome
7 April 2020 - - US-based biopharmaceutical company Millendo Therapeutics, Inc. (NASDAQ: MLND) is discontinuing the development of livoletide as a potential treatment for Prader-Willi syndrome, t...
FARXIGA Phase III DAPA-CKD Trial Will Be Stopped Early After Overwhelming Efficacy in Patients with Chronic Kidney Disease
2 April 2020 - - The Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) Phase III trial for FARXIGA (dapagliflozin) in p...
Zealand Pharma announces return of worldwide rights to Amylin analog programme from Boehringer Ingelheim
23 March 2020 - Zealand Pharma A/S (Zealand) (CPH:ZEAL), a biotechnology company focused on the discovery and development of innovative peptide-based medicines, announced on Friday the return by Boehr...
Vivify Health Offers Rapid Deployment Plan for Providers to Screen and Monitor Patients Remotely
17 March 2020 - - US-based connected care platform provider Vivify Health has launched a new COVID-19 Screening, Self-Isolation and Monitoring Pathways for its Vivify +Go mobile solution, as part of i...
US FDA grants Fast Track Designation to Empagliflozin for the Treatment of Chronic Kidney Disease
13 March 2020 - - The US Food and Drug Administration has granted Fast Track designation for the investigation of empagliflozin to reduce the risk of kidney disease progression and cardiovascular deat...
Provention Bio reports 2019 financial results
13 March 2020 - Provention Bio Inc (Nasdaq: PRVB), a clinical-stage biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, announced on Thursday, its financial re...